Navin R Pinto

19PUBLICATIONS

139CO-AUTHORS

Molecular targetsInformation systems development methodologies and practiceRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (19)

Sort by Publication Date:

|Jun 18, 2026

The first-in-human ENCIT01 trial comparing second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastoma.

|Jan 22, 2026

Introducing iCatalog as a clinical decision support tool for collaborative pediatric precision oncology studies.

Wenjun Kang, Lorena Lazo de la Vega, Hannah Comeau

|Jun 23, 2025

Phase I Study of <sup>131</sup>I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial.

Thomas Cash, Araz Marachelian, Steven G DuBois

|Jan 08, 2025

Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial.

Nicholas A Vitanza, Rebecca Ronsley, Michelle Choe

|Sep 10, 2024

STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors.

Navin Pinto, Catherine M Albert, Mallory R Taylor

|Apr 03, 2023

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.

Kelly C Goldsmith, Julie R Park, Kimberly Kayser

Pageof 4

Frequent Collaborators

Julie R Park

Margaret E Macy

Wenjun Huang

Steven G DuBois

Rebecca A Gardner

Luke Maese

Nicholas A Vitanza

Ashley L Wilson

Meredith S Irwin

Michael C Jensen

Frequent Collaborators

Julie R Park

Margaret E Macy

Wenjun Huang

Steven G DuBois